Cystadrops (cysteamine 0.37% ophthalmic solution) — Medica
Cystinosis with corneal cysteine crystal deposits
Initial criteria
- Patient has corneal cysteine crystal deposits confirmed by slit-lamp examination
- Medication is prescribed by or in consultation with an ophthalmologist or a metabolic disease specialist (or specialist who focuses in the treatment of metabolic diseases)
Approval duration
1 year